It's been an outstanding year for fledgling biotechnology companies across the board, but these three haven't fared as well as the rest of their industry in recent weeks.
All of these biotech stocks have been battered for different reasons, and bouncing back will be a lot easier for some than for others.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,